{"anger": 2.88, "aspartate aminotransferase increased": 2.02, "balance disorder": 5.77, "bladder disorder": 25.51, "bronchitis": 2.03, "burning sensation": 2.09, "central nervous system lesion": 33.0, "cognitive disorder": 2.75, "cystitis": 3.79, "depressed mood": 4.62, "depression": 7.63, "device issue": 3.38, "diplopia": 4.0, "eye disorder": 2.01, "fall": 2.86, "fear of injection": 24.65, "feeling abnormal": 2.75, "gait disturbance": 8.43, "gait inability": 3.01, "gamma-glutamyltransferase increased": 2.81, "hemiplegia": 3.77, "hepatic enzyme increased": 2.85, "hypoaesthesia": 3.86, "hypokinesia": 3.61, "influenza like illness": 3.47, "injection site abscess": 39.77, "injection site bruising": 42.23, "injection site discolouration": 53.8, "injection site discomfort": 4.85, "injection site erythema": 8.76, "injection site haematoma": 2.6, "injection site haemorrhage": 6.0, "injection site induration": 6.0, "injection site irritation": 63.4, "injection site mass": 9.31, "injection site necrosis": 67.16, "injection site pain": 2.17, "injection site pruritus": 3.18, "injection site rash": 7.77, "injection site reaction": 5.2, "injection site urticaria": 8.99, "intervertebral disc protrusion": 3.44, "liver function test increased": 4.0, "mental disorder": 4.42, "mood altered": 2.44, "motor dysfunction": 4.44, "movement disorder": 3.22, "multiple sclerosis": 10.64, "multiple sclerosis relapse": 106.44, "muscle rigidity": 4.84, "muscle spasms": 2.37, "muscle spasticity": 22.63, "muscle tightness": 2.99, "muscular weakness": 2.84, "nasopharyngitis": 3.72, "optic neuritis": 15.82, "paresis": 7.06, "road traffic accident": 3.12, "sensory disturbance": 4.6, "skin disorder": 3.64, "skin irritation": 18.97, "skin reaction": 3.76, "speech disorder": 2.7, "stress": 11.67, "temperature intolerance": 23.77, "trigeminal neuralgia": 3.91, "urinary incontinence": 2.72, "visual impairment": 2.33, "walking aid user": 13.42, "wrong technique in product usage process": 2.16}